Reading Time: 2 minutesShare To X Share to Gab () Introduction Hypogonadism, characterized by deficient testosterone production, affects millions of American men, with prevalence rates escalating to over 30% in those aged 65 and older, according to data from the National Health and Nutrition Examination Survey (NHANES). This endocrine disorder manifests as fatigue, diminished libido, erectile dysfunction, reduced muscle mass, and increased adiposity, profoundly impacting quality of life. Traditional testosterone replacement therapies (TRT), such as intramuscular injections and transdermal gels, have limitations including injection-site pain, skin irritation, and variable pharmacokinetics. Enter Kyzatrex, an innovative oral testosterone undecanoate capsule approved by the FDA in … Continue reading Kyzatrex: Restoring Hormonal Balance in Hypogonadal American Men via Oral TRT